Immunotherapy — RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial
Citation(s)
Radiofrequency Ablation or Surgical Resection Combined With Neo-MASCT for Primary Hepatocellular Carcinoma: a Randomised, Multicentre Phase II Trial